Epithelial NF-kappaB enhances transmucosal fluid movement by altering tight junction protein composition after T cell activation.
about
Claudins in intestines: Distribution and functional significance in health and diseasesTU-100 (Daikenchuto) and ginger ameliorate anti-CD3 antibody induced T cell-mediated murine enteritis: microbe-independent effects involving Akt and NF-κB suppressionMicrobial ecology of the murine gut associated with the development of dextran sodium sulfate-induced colitis.Intestinal inflammation and mucosal barrier function.Claudins and the modulation of tight junction permeability.Lipopolysaccharide disrupts the milk-blood barrier by modulating claudins in mammary alveolar tight junctions.An adenosine A3 receptor agonist inhibits DSS-induced colitis in mice through modulation of the NF-κB signaling pathway.New molecular insights into inflammatory bowel disease-induced diarrhea.Enterocyte STAT5 promotes mucosal wound healing via suppression of myosin light chain kinase-mediated loss of barrier function and inflammation.Myosin light chain kinase: pulling the strings of epithelial tight junction functionp53 mediates TNF-induced epithelial cell apoptosis in IBD.MicroRNA-16 is putatively involved in the NF-κB pathway regulation in ulcerative colitis through adenosine A2a receptor (A2aAR) mRNA targetingInnate immune signalling at the intestinal epithelium in homeostasis and disease.Epithelial TNF Receptor Signaling Promotes Mucosal Repair in Inflammatory Bowel Disease.Increased intestinal permeability and tight junction disruption by altered expression and localization of occludin in a murine graft versus host disease model.The NF-κB target genes ICAM-1 and VCAM-1 are differentially regulated during spontaneous differentiation of Caco-2 cells.The ginger component 6-shogaol prevents TNF-α-induced barrier loss via inhibition of PI3K/Akt and NF-κB signaling.Enteropathogenic E. coli effectors EspG1/G2 disrupt microtubules, contribute to tight junction perturbation and inhibit restorationMicroarray Analyses of Genes Differentially Expressed by Diet (Black Beans and Soy Flour) during Azoxymethane-Induced Colon Carcinogenesis in Rats.Oral glutamine supplementation improves intestinal permeability dysfunction in a murine acute graft-vs.-host disease model.Butyrate protects against disruption of the blood-milk barrier and moderates inflammatory responses in a model of mastitis induced by lipopolysaccharide.NF-κB activity in perinatal brain during infectious and hypoxic-ischemic insults revealed by a reporter mouse.Tumour necrosis factor--induced loss of intestinal barrier function requires TNFR1 and TNFR2 signalling in a mouse model of total parenteral nutrition.VBP15, a novel dissociative steroid compound, reduces NFκB-induced expression of inflammatory cytokines in vitro and symptoms of murine trinitrobenzene sulfonic acid-induced colitis.Anti-mouse CD52 monoclonal antibody ameliorates intestinal epithelial barrier function in interleukin-10 knockout mice with spontaneous chronic colitis.
P2860
Q27000548-23C20BFA-1B72-4A0F-8A12-F3EBEC48053EQ33654829-F1F43247-9BE9-4D8E-B322-FD5ED016DDCDQ33842489-28F0B48E-5EA3-4061-B272-919638856782Q34438743-42517332-7E38-4366-9154-8ACEEA512BF5Q34650517-6D538494-ACAB-4B03-8477-DE80F8CC4078Q34692863-535B6C7C-FE37-45D0-A76A-B73D053CA73BQ35169625-3B4C0135-68DE-49AD-A6CC-F8A1765C4827Q35582973-3AB426F6-4B6A-4F97-BFEC-9898C405BC6AQ35836695-AF63ABEA-F180-4059-A807-6FE7CEB7953FQ36062835-CF6D203D-820D-42AB-B1D1-6A6076292CC2Q36295461-B1681428-A6A4-467F-BD42-CAA7723686F7Q37141104-79DB7150-CB97-415A-A76F-9628DF90FC88Q38026748-DD0D5AB5-4E9D-4076-99C7-7381CC1DCE2EQ38659479-C1F0B6E0-34BC-4455-BFF3-DD57CDBA3064Q38784025-F3C4AD85-DCFE-4033-8837-A3863B669970Q39323558-B2D98B43-1DB3-40A7-84C2-4271FA282F9EQ40589608-B9ED91EF-8058-45F9-B549-3CDE09D814D4Q41506828-0F9B44DB-16A1-4F51-AFD2-2C6F56D43779Q42577402-0CDBC3F4-4026-4A40-A507-DE8070274B6DQ43716527-A146E52A-22D2-48C8-886B-40547E88CBA5Q47963493-BCD502CD-5F6C-41F8-9271-32643F75B9A7Q50508300-35154961-C745-474D-B482-67907D983923Q50920142-C292F237-8EC5-42B4-8538-1E5E4CDA621EQ51720780-65FF827A-2D9A-4A1F-B18B-1D4BFE65731AQ54333269-72BD4BCF-C834-4604-91A6-1B44E4BCFF1A
P2860
Epithelial NF-kappaB enhances transmucosal fluid movement by altering tight junction protein composition after T cell activation.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Epithelial NF-kappaB enhances ...... ition after T cell activation.
@ast
Epithelial NF-kappaB enhances ...... ition after T cell activation.
@en
Epithelial NF-kappaB enhances ...... ition after T cell activation.
@nl
type
label
Epithelial NF-kappaB enhances ...... ition after T cell activation.
@ast
Epithelial NF-kappaB enhances ...... ition after T cell activation.
@en
Epithelial NF-kappaB enhances ...... ition after T cell activation.
@nl
prefLabel
Epithelial NF-kappaB enhances ...... ition after T cell activation.
@ast
Epithelial NF-kappaB enhances ...... ition after T cell activation.
@en
Epithelial NF-kappaB enhances ...... ition after T cell activation.
@nl
P2093
P2860
P1476
Epithelial NF-kappaB enhances ...... ition after T cell activation.
@en
P2093
David Ivancic
Gery Grimm
Jerrold R Turner
Jonathan Fryer
Michelle Kron
Navdha Mittal
Ramanarao Dirisina
Rebecca B Katzman
Tatiana Goretsky
P2860
P304
P356
10.2353/AJPATH.2010.090548
P407
P577
2009-12-11T00:00:00Z